In early 2014, Marle integrated a plasma torch, which allows for the production of hydroxyapatite (HAP), a ceramic-based coating powder in a monolayer application. This investment will complement the technologies mastered internally by the leader of the industrial manufacturing of orthopedic implants in Europe.
There are three main families of bioactive ceramic coatings for orthopedic implants: hydroxyapatite layer coating on titanium, titanium coating monolayer on titanium parts, stainless steel or chrome-cobalt, and bilayer coating, which combines a projection of titanium and hydroxyapatite layer.
Marle's teams have been producing hydroxyapatite-coated implants for nearly 30 years, working with carefully selected partners in the plasma-spray technology.
Increasingly comprehensive production services
Implementation of a plasma torch in our factory meets the regulatory changes, which by 2015, will force managers of orthopedics complete control of processes from their suppliers. Our goal is to offer a complete, unique and easier to implement service, and most importantly, easier to audit, monitor and evaluate.
Marle is the only subcontractor in France to offer a complete manufacturing solution, and thus differs significantly from the smiths, founders, machinists or finishing services on the market.
This fully validated process, under a Masterfile filing with the Food and Drug Administration (FDA) in the United States, will enable our customers to accelerate the authorization procedures for market placing.